Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Recent Advancements in and the Future of Organic Emitters: TADF- and RTP-Active Multifunctional Organic Materials.

ABSTRACT: Organic emitting compounds that are based on ?-conjugated skeletons have emerged as promising next-generation materials for application in optoelectronic devices. In this Minireview, recent advances in the development of organic emitters that irradiate room-temperature phosphorescence and/or thermally activated delayed fluorescence with extraordinary luminescence properties, such as aggregation-induced emission, mechanochromic luminescence, and circularly polarized luminescence, are discussed.

SUBMITTER: Data P

PROVIDER: S-EPMC6590235 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Recent Advancements in and the Future of Organic Emitters: TADF- and RTP-Active Multifunctional Organic Materials.

Data Przemyslaw P Takeda Youhei Y

Chemistry, an Asian journal 20190128 10

Organic emitting compounds that are based on π-conjugated skeletons have emerged as promising next-generation materials for application in optoelectronic devices. In this Minireview, recent advances in the development of organic emitters that irradiate room-temperature phosphorescence and/or thermally activated delayed fluorescence with extraordinary luminescence properties, such as aggregation-induced emission, mechanochromic luminescence, and circularly polarized luminescence, are discussed. ...[more]

PMID: 30609306

Similar Datasets

Switching between TADF and RTP: anion-regulated photoluminescence in organic salts and co-crystals.

Project description:Thermally activated delayed fluorescence (TADF) and room temperature phosphorescence (RTP) are two photophysical phenomena which utilize triplet excitons. In this work, we demonstrate how variation of the anion in organic salts with carbazole and phenothiazine-5,5-dioxide donors and pyridinium and quinolinium acceptors may be used to switch between TADF and RTP. These compounds adopt similar molecular structures and packing modes with different anions and exhibit different types of photophysical behavior due to the electronic effects of the anions. With bromide anions, the salts exhibit TADF with some RTP. These compounds show fast reverse intersystem crossing and a short delayed lifetime, which is key to application in efficient and robust OLEDs. With BF4 - and PF6 - anions, RTP with long-lived lifetimes and afterglow are observed by eye. This behavior can be utilized for data encryption and anti-counterfeiting applications. Emission wavelengths and lifetimes are also anion-dependent. These results open up an avenue for developing novel luminescent materials through anion tuning and present a molecular model to understand the interplay of RTP and TADF.

| S-EPMC8406714 | biostudies-literature

Immunotherapy in Melanoma: Recent Advancements and Future Directions.

Project description:Immune checkpoint inhibition has fundamentally altered the treatment paradigm of resectable and unresectable melanoma, resulting in dramatic improvements in patient outcomes. With these advances, the five-year overall survival in patients with newly diagnosed unresectable disease has eclipsed 50%. Ongoing research is focused on improving outcomes further, with a considerable emphasis on preventing de novo and acquired resistance and personalizing therapeutic options. Here, we review the ongoing advancements in the treatment of malignant melanoma, focusing on novel combination strategies that aim to build upon the successes of the last decade.

| S-EPMC10452647 | biostudies-literature

What Controls the Orientation of TADF Emitters?

Project description:Thermally-activated delayed fluorescence (TADF) emitters-just like phosphorescent ones-can in principle allow for 100% internal quantum efficiency of organic light-emitting diodes (OLEDs), because the initially formed electron-hole pairs in the non-emissive triplet state can be efficiently converted into emissive singlets by reverse intersystem crossing. However, as compared to phosphorescent emitter complexes with their bulky-often close to spherical-molecular structures, TADF emitters offer the advantage to align them such that their optical transition dipole moments (TDMs) lie preferentially in the film plane. In this report, we address the question which factors control the orientation of TADF emitters. Specifically, we discuss how guest-host interactions may be used to influence this parameter and propose an interplay of different factors being responsible. We infer that emitter orientation is mainly governed by the molecular shape of the TADF molecule itself and by the physical properties of the host-foremost, its glass transition temperature Tg and its tendency for alignment being expressed, e.g., as birefringence or the formation of a giant surface potential of the host. Electrostatic dipole-dipole interactions between host and emitter are not found to play an important role.

| S-EPMC7500207 | biostudies-literature

Corrigendum: What Controls the Orientation of TADF Emitters?

Project description:[This corrects the article DOI: 10.3389/fchem.2020.00750.].

| S-EPMC7927789 | biostudies-literature

Molecular design to regulate the photophysical properties of multifunctional TADF emitters towards high-performance TADF-based OLEDs with EQEs up to 22.4% and small efficiency roll-offs.

Project description:Simultaneously achieving high efficiency and low efficiency roll-off remains a big challenge for OLEDs based on thermally activated delayed fluorescence (TADF) emitters. To address this issue, we elaborately designed and synthesized a series of new emitters with both TADF and aggregation-induced emission (AIE) properties by introducing 9,9-dimethyl-9,10-dihydroacridine (DMAC) or 10H-phenoxazine (PXZ) as donor units into a quinoxaline framework. By tuning the electron-donating capability of the donor as well as the amount of donor unit, the photophysical properties of the TADF-AIE emitters can be systematically regulated, with emissions ranging from green to red. We demonstrated efficient doped OLEDs with a maximum EQE of 22.4%, a maximum current efficiency (CEmax) of 80.3 cd A-1 and a maximum power efficiency (PEmax) of 64.1 lm W-1 for the green device, and an EQEmax of 14.1%, a CEmax of 36.1 cd A-1 and a PEmax of 28.1 lm W-1 for the orange device. Remarkably, these orange devices rendered small roll-offs of 1.4% and 21.3% respectively at a luminance of 100 and 1000 cd m-2. Attributed to the unique TADF and AIE features, the non-doped devices perform outstandingly with an EQEmax of 12.0%, a CEmax of 41.2 cd A-1 and a PEmax of 45.4 lm W-1.

| S-EPMC5885939 | biostudies-literature

Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives.

Project description:This mini-review explores recent advancements in cancer vaccines that target Wilms' tumor (WT1). Phase I/II trials of WT1 peptide vaccines have demonstrated their safety and efficacy against various cancers. Early trials employing HLA class I peptides evolved through their combination with HLA class II peptides, resulting in improved clinical outcomes. Additionally, WT1-targeted dendritic cell vaccines have exhibited favorable results. Studies focusing on hematological malignancies have revealed promising outcomes, including long-term remission and extended survival times. The combination of vaccines with immune checkpoint inhibitors has shown synergistic effects. Current preclinical developments are focused on enhancing the effectiveness of WT1 vaccines, underscoring the necessity for future large-scale Phase III trials to further elucidate their efficacy.

| S-EPMC10760787 | biostudies-literature

Virtual Screening of TADF Emitters for Single-Layer OLEDs.

Project description:Thermally-activated delayed fluorescence (TADF) is a concept which helps to harvest triplet excitations, boosting the efficiency of an organic light-emitting diode. TADF can be observed in molecules with spatially separated donor and acceptor groups with a reduced triplet-singlet energy level splitting. TADF materials with balanced electron and hole transport are attractive for realizing efficient single-layer organic light emitting diodes, greatly simplifying their manufacturing and improving their stability. Our goal here is to computationally screen such materials and provide a comprehensive database of compounds with a range of emission wavelengths, ionization energies, and electron affinities.

| S-EPMC8716429 | biostudies-literature

Molecular Design Strategies for Color Tuning of Blue TADF Emitters.

Project description:New thermally activated delayed fluorescence (TADF) blue emitter molecules based on the known donor-acceptor-donor (D-A-D)-type TADF molecule, 2,7-bis(9,9-dimethylacridin-10-yl)-9,9-dimethylthioxanthene-S,S-dioxide (DDMA-TXO2), are reported. The motivation for the present investigation is via the use of rational molecular design, based on DDMA-TXO2, to elevate the organic light emitting diode (OLED) performance and obtain deeper blue color coordinates. To achieve this goal, the strength of the donor (D) unit and acceptor (A) units have been tuned with methyl substituents. The methyl functionality on the acceptor was also expected to modulate the D-A torsion angle in order to obtain a blue shift in the electroluminescence. The effect of regioisomeric structures has also been investigated. Herein, we report the photophysical, electrochemical, and single-crystal X-ray crystallography data to assist with the successful OLED design. The methyl substituents on the DDMA-TXO2 framework have profound effects on the photophysics and color coordinates of the emitters. The weak electron-donating methyl groups alter the redox properties of the D and A units and consequently affect the singlet and triplet levels but not the energy gap (ΔEST). By systematically manipulating all of the aforementioned factors, devices have been obtained with acceptor-substituted III with a maximum external quantum efficiency of 22.6% and Commission Internationale de l'Éclairage coordinates of (0.15, 0.18) at 1000 cd m-2.

| S-EPMC7006999 | biostudies-literature

Multifunctional nanodiamonds in regenerative medicine: Recent advances and future directions.

Project description:With recent advances in the field of nanomedicine, many new strategies have emerged for diagnosing and treating diseases. At the forefront of this multidisciplinary research, carbon nanomaterials have demonstrated unprecedented potential for a variety of regenerative medicine applications including novel drug delivery platforms that facilitate the localized and sustained release of therapeutics. Nanodiamonds (NDs) are a unique class of carbon nanoparticles that are gaining increasing attention for their biocompatibility, highly functional surfaces, optical properties, and robust physical properties. Their remarkable features have established NDs as an invaluable regenerative medicine platform, with a broad range of clinically relevant applications ranging from targeted delivery systems for insoluble drugs, bioactive substrates for stem cells, and fluorescent probes for long-term tracking of cells and biomolecules in vitro and in vivo. This review introduces the synthesis techniques and the various routes of surface functionalization that allow for precise control over the properties of NDs. It also provides an in-depth overview of the current progress made toward the use of NDs in the fields of drug delivery, tissue engineering, and bioimaging. Their future outlook in regenerative medicine including the current clinical significance of NDs, as well as the challenges that must be overcome to successfully translate the reviewed technologies from research platforms to clinical therapies will also be discussed.

| S-EPMC5560434 | biostudies-literature

Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future.

Project description:The theranostic approach in oncology holds significant importance in personalized medicine and stands as an exciting field of molecular medicine. Significant achievements have been made in this field in recent decades, particularly in treating neuroendocrine tumors using 177-Lu-radiolabeled somatostatin analogs and, more recently, in addressing prostate cancer through prostate-specific-membrane-antigen targeted radionuclide therapy. The promising clinical results obtained in these indications paved the way for the further development of this approach. With the continuous discovery of new molecular players in tumorigenesis, the development of novel radiopharmaceuticals, and the potential combination of theranostics agents with immunotherapy, nuclear medicine is poised for significant advancements. The strategy of theranostics in oncology can be categorized into (1) repurposing nuclear medicine agents for other indications, (2) improving existing radiopharmaceuticals, and (3) developing new theranostics agents for tumor-specific antigens. In this review, we provide an overview of theranostic development and shed light on its potential integration into combined treatment strategies.

| S-EPMC10572076 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data